Reactions Weekly

, Volume 1091, Issue 1, pp 2–2 | Cite as

US FDA releases hold on Tysabri trial

Media release
  • 5 Downloads

Keywords

Rheumatoid Arthritis Multiple Sclerosis Progressive Multifocal Leukoencephalopathy Natalizumab Safety Evaluation 

Copyright information

© Adis International limited or Adis Data Information BV 2006

Personalised recommendations